Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 36 holding rows worth $1,400,537,000.

Accession
0001546927-15-000145
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 37 entries on the cover page, a total value of $1,400,537,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,400,537,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,000,000$206,430,000thousands by filing dateput
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,650,000$102,795,000thousands by filing date
MASIMO CORP COM574795100Stock2,700,000$89,046,000thousands by filing date
MEDICINES CO584688105COM2,500,000$70,050,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM2,100,000$64,155,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM700,000$60,739,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM7,000,000$57,680,000thousands by filing date
UNIVERSAL AMERN CORP NEW91338E101COM5,234,898$55,909,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM1,018,246$55,657,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM1,500,000$53,835,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW400,000$50,436,000thousands by filing date
CYBERONICS23251P102COMMON STOCK750,000$48,690,000thousands by filing date
SELECT MED HLDGS CORP81619Q105COM3,000,000$44,490,000thousands by filing date
AbbVie,Inc.00287Y109COM750,000$43,905,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK3,000,000$38,190,000thousands by filing date
BRUKER CORP116794108COM2,000,000$36,940,000thousands by filing date
KINDRED HEALTHCARE INC494580103COM1,500,000$35,685,000thousands by filing date
SEQUENOM INC COM NEW817337405COM9,000,000$35,550,000thousands by filing date
CONMED CORP COM207410101Stock670,943$33,876,000thousands by filing date
ARENA PHARMECEUTICALS INC040047102COMMON STOCK7,500,000$32,775,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW12,000,000$28,080,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM1,482,662$19,245,000thousands by filing date
TREVENA INC89532E109COM2,870,000$18,712,000thousands by filing date
CROSS CTRY HEALTHCARE INC227483104COM1,422,565$16,872,000thousands by filing date
EPIRUS Biopharmaceuticals Inc29428P107Common Stock1,847,500$16,535,000thousands by filing date
BIOSCRIP INC09069N108COM3,000,000$13,290,000thousands by filing date
ANGIODYNAMICS INC03475V101COM728,483$12,960,000thousands by filing date
VERADIGM INC01988P108COMMON STOCK1,000,000$11,960,000thousands by filing date
BIOLASE INC090911108COMMON STOCK7,388,867$11,283,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365A101COM9,000,000$6,904,000thousands by filing dateprincipal
INVITAE CORP46185L103COM400,000$6,704,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM864,223$5,652,000thousands by filing date
CARDICA INC14141R101COM8,374,846$5,274,000thousands by filing date
TARGACEPT INC87611R306COM1,560,000$4,633,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/12,000,000$3,560,000thousands by filing date
INOVIO PHARMACEUTICALS INC45773H201COM NEW250,000$2,040,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001546927-15-000145this filing2015-05-15acceptance time not in the bulk data set